SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs ZEUS System (Zio Watch)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

ZEUS System (Zio Watch)

by iRhythm Technologies

AI Verdict

Tool A is designed for point-of-care diagnostic assistance, analyzing acoustic heart signals from an electronic stethoscope to differentiate heart murmurs. In contrast, Tool B provides long-term continuous cardiac monitoring via a wearable device to detect and characterize arrhythmias, particularly Atrial Fibrillation. While both leverage AI in cardiology, their distinct data acquisition methods and primary clinical applications make them adjacent rather than direct competitors.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI if you need an immediate, AI-assisted diagnostic aid at the point of care to differentiate between physiological and pathological heart murmurs. This tool is ideal for physicians seeking to quickly analyze acoustic heart signals from an electronic stethoscope to inform initial assessment and referral decisions for patients presenting with suspected murmurs.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose ZEUS System (Zio Watch) if…

Choose ZEUS System (Zio Watch) if you require long-term, continuous cardiac monitoring to detect and characterize intermittent arrhythmias, especially Atrial Fibrillation (AFib). This wearable solution is best suited for patients needing extended observation (up to 14 days) to capture elusive cardiac events that might be missed by shorter-duration monitoring methods, providing comprehensive data for diagnosis and management.

View ZEUS System (Zio Watch) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	ZEUS System (Zio Watch)
Pricing	Contact for pricing	Contact vendor
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Cloud-based system with a wearable device
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System (Zio Watch)

Tool B offers a more comprehensive and integrated user experience with its wearable device for continuous monitoring, a patient-facing app for engagement, and a dedicated provider portal and mobile app for streamlined workflow and patient management. Tool A, while mobile, requires active, point-in-time physician interaction with a separate stethoscope.

Clinical Value

ZEUS System (Zio Watch)

Both tools are FDA-cleared and provide valuable clinical decision support. However, Tool B's long-term continuous monitoring for arrhythmias, coupled with a high 99% physician agreement on its clinically actionable reports, suggests a broader and highly validated impact on managing chronic cardiac conditions.

Pricing & Value

Tie

Neither tool provides publicly available pricing information, making it impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition. Both require direct contact with the vendor for pricing details.

Enterprise Readiness

ZEUS System (Zio Watch)

Both tools are HIPAA compliant and offer BAAs, essential for enterprise use. However, Tool B's cloud-based deployment, along with its integrated ZioSuite portal and provider mobile app, suggests a more scalable and easily manageable solution for large healthcare organizations.

Innovation

ZEUS System (Zio Watch)

While both utilize AI for cardiac diagnostics, Tool B's innovation in offering a wearable device for long-term continuous monitoring of ECG and PPG data, specifically for complex arrhythmias like AFib, represents a more advanced and comprehensive approach to remote patient monitoring.

Support & Docs

ZEUS System (Zio Watch)

iRhythm Technologies (Tool B) provides extensive support resources, including 24/7 patient support, dedicated provider support, FAQs, and detailed manuals for its ZioSuite portal and system. In contrast, SensiCardiac Mobi (Tool A) has a user manual available but lacks readily apparent dedicated support channels.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	ZEUS System (Zio Watch)
Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	ZEUS System (Zio Watch)
Primary Function	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals to differentiate between physiological and pathological sounds.	Long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias.
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	iRhythm Technologies
Key Technology/Device	AI-powered mobile application, requires a compatible electronic stethoscope (user-provided)	Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection, AI-powered algorithm (ZEUS System)
Target Conditions	Heart murmurs (differentiating normal/physiological and pathological)	Atrial Fibrillation (AFib) and other cardiac arrhythmias
Monitoring Duration	Not specified	Up to 14 days
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and ZEUS System (Zio Watch).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the key differences in how each tool integrates into a physician's existing clinical workflow for patient assessment and diagnosis?

SensiCardiac Mobi integrates into a point-of-care workflow by acquiring and recording acoustic heart signals from an electronic stethoscope via a mobile application to assist in diagnosing heart murmurs. The ZEUS System involves a wearable biosensor for continuous ECG and PPG data collection, with data processed in a cloud-based system, and reports interpreted via a provider portal or mobile app for long-term arrhythmia monitoring.

Can you elaborate on the specific performance metrics, such as sensitivity and specificity, for each tool in its respective diagnostic application (heart murmur differentiation vs. arrhythmia detection)?

SensiCardiac Mobi analyzes heart sounds using its algorithm to distinguish between normal/physiological and pathological heart murmurs, identifying S1, S2, and suspected murmurs. The ZEUS System uses an AI-powered algorithm for advanced arrhythmia detection and analysis, providing clinically actionable reports with high physician agreement (99%) for detecting and characterizing AFib burden.

What level of integration is available with common Electronic Health Record (EHR) systems, and how is patient data and diagnostic information transferred and incorporated into patient charts?

The provided information for SensiCardiac Mobi does not specify EHR integration depth, only mentioning a mobile application for data capture and display. The ZEUS System utilizes cloud-based data analytics and processing, with reports accessible via the ZioSuite portal and provider mobile app, but specific EHR integration depth is not detailed.

What is the typical learning curve for physicians and their clinical staff to become proficient with each system, and what training resources are provided?

SensiCardiac Mobi operates as a mobile application for data capture and display, requiring a compatible electronic stethoscope, suggesting a focus on straightforward point-of-care use. The ZEUS System involves a wearable device, a cloud-based system, a provider portal (ZioSuite), and a patient app (MyZio), indicating a broader ecosystem for physicians and patients to learn.

For which specific patient populations or clinical scenarios is each tool most optimally suited, considering their distinct functionalities?

SensiCardiac Mobi is optimally suited for assisting physicians in diagnosing heart murmurs, particularly in cardiology, internal medicine, and pediatrics, by differentiating between physiological and pathological sounds. The ZEUS System is specifically designed for long-term continuous cardiac monitoring to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias, providing actionable insights for cardiology, family medicine, and internal medicine.

What considerations should be made for rolling out these tools across multiple clinic sites, and what ongoing support is provided for larger practices?

The description for SensiCardiac Mobi mentions a hosted server environment and mobile application, but specific considerations for multi-site rollouts or details on ongoing support quality are not provided. The ZEUS System is a cloud-based system with a provider portal and patient app, which inherently supports remote access and management, but specific multi-site rollout considerations or detailed support quality are not explicitly stated.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION or ZEUS System (Zio Watch)

Backers

Who funded each tool's parent company.